Bill Commons

HI SB 2106

died on adjournment

RELATING TO HEALTH.

Hawaii · 2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did HI SB 2106 pass?

No. HI SB 2106 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-26): The committee on CPN deferred the measure.

What is HI SB 2106 about?

Prohibits the sale of nonprescription diet pills and dietary supplements for weight loss or muscle building to any person under eighteen years of age. Requires retail establishments and delivery sellers to follow certain protocols regarding certain products to prevent access by minors to the restricted products. Effective 1/30/2050. (SD1)

Who sponsors HI SB 2106?

GABBARD, MCKELVEY, RHOADS are the primary sponsors of HI SB 2106, joined by 2 cosponsors.

Description

Prohibits the sale of nonprescription diet pills and dietary supplements for weight loss or muscle building to any person under eighteen years of age. Requires retail establishments and delivery sellers to follow certain protocols regarding certain products to prevent access by minors to the restricted products. Effective 1/30/2050. (SD1)

Introduced
2026-01-21
Latest action
2026-02-26 — The committee on CPN deferred the measure.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • GABBARDprimary
  • MCKELVEYprimary
  • RHOADSprimary
  • Moriwakicosponsor
  • San Buenaventuracosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-02-26

    The committee on CPN deferred the measure.

    deferral

  2. 2026-02-20

    The committee(s) on CPN will hold a public decision making on 02-26-26 9:45AM; Conference Room 229 & Videoconference.

  3. 2026-02-11

    Reported from HHS (Stand. Com. Rep. No. 2197) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN.

  4. 2026-02-11

    Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN.

    passage,reading-2,referral-committee

  5. 2026-02-02

    The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: Senator(s) McKelvey ; 0 No(es): none; and 0 Excused: none.

    committee-passage-favorable

  6. 2026-01-30

    The committee(s) on HHS has scheduled a public hearing on 02-02-26 1:05PM; Conference Room 225 & Videoconference.

  7. 2026-01-22

    Referred to HHS, CPN.

    referral-committee

  8. 2026-01-21

    Introduced and passed First Reading.

    introduction,reading-1

  9. 2026-01-14

    Pending Introduction.

Versions

Documents

Votes

  • The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS.

    2026-02-02 · pass · 5-0

    Member-level votes (5)
    • San Buenaventura: yes
    • Kanuha: yes
    • Keohokalole: yes
    • Fevella: yes
    • McKelvey: yes

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=SB 2106. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.